Identification of a novel synthetic lethality of combined inhibition of hedgehog and PI3K signaling in rhabdomyosarcoma

Oncotarget
Ulrike GraabSimone Fulda

Abstract

We previously reported that aberrant HH pathway activation confers a poor prognosis in rhabdomyosarcoma (RMS). Searching for new treatment strategies we therefore targeted HH signaling. Here, we identify a novel synthetic lethality of concomitant inhibition of HH and PI3K/AKT/mTOR pathways in RMS by GLI1/2 inhibitor GANT61 and PI3K/mTOR inhibitor PI103. Synergistic drug interaction is confirmed by calculation of combination index (CI < 0.2). Similarly, genetic silencing of GLI1/2 significantly increases PI103-induced apoptosis. GANT61 and PI103 also synergize to induce apoptosis in cultured primary RMS cells emphasizing the clinical relevance of this combination. Importantly, GANT61/PI103 cotreatment suppresses clonogenic survival, three-dimensional sphere formation and tumor growth in an in vivo model of RMS. Mechanistic studies reveal that GANT61 and PI103 cooperate to trigger caspase-dependent apoptosis via the mitochondrial pathway, as demonstrated by several lines of evidence. First, GANT61/PI103 cotreatment increases mRNA and protein expression of NOXA and BMF, which is required for apoptosis, since knockdown of NOXA or BMF significantly reduces GANT61/PI103-induced apoptosis. Second, GANT61/PI103 cotreatment triggers BAK...Continue Reading

References

May 23, 2002·Biochimie·Kelvin CainGerald M Cohen
Aug 31, 2002·Human Mutation·Julia Calzada-WackHeidi Hahn
Dec 31, 2002·The Journal of Biological Chemistry·Hua ZouRobert C Armstrong
Mar 23, 2007·Nature Reviews. Molecular Cell Biology·Stefan J Riedl, Guy S Salvesen
Mar 30, 2007·Proceedings of the National Academy of Sciences of the United States of America·Barbara SteccaAriel Ruiz I Altaba
May 15, 2007·Proceedings of the National Academy of Sciences of the United States of America·Matthias LauthRune Toftgård
Jul 17, 2007·Current Opinion in Immunology·Jerry M Adams, Suzanne Cory
Jul 27, 2007·Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico·S Gallego Melcón, J Sánchez de Toledo Codina
Sep 17, 2008·Genes & Development·Markku Varjosalo, Jussi Taipale
Nov 13, 2008·International Journal of Cancer. Journal International Du Cancer·Simone Fulda
Sep 1, 2009·Bioorganic & Medicinal Chemistry Letters·Kirk D RobargeMinli Xie
Jul 14, 2010·Proceedings of the National Academy of Sciences of the United States of America·Jynho KimPhilip A Beachy
Aug 14, 2010·Cell Death and Differentiation·F GrespiA Villunger
Sep 15, 2010·International Journal of Cancer. Journal International Du Cancer·Lingyun Wei, Zhifei Xu
Dec 25, 2010·The Journal of Clinical Investigation·Elspeth M BeauchampAykut Uren
Mar 24, 2012·Cancer Cell·Yan WangMien-Chie Hung
Apr 5, 2012·The Journal of Biological Chemistry·Kaitlyn E Ryan, Chin Chiang
Jun 8, 2012·The New England Journal of Medicine·Aleksandar SekulicAxel Hauschild
Oct 12, 2013·Advances in Anatomic Pathology·David M Parham, Frederic G Barr
Mar 13, 2014·Cancer Treatment Reviews·Jillian BrechbielAlex A Adjei
Mar 22, 2014·Cancer Cell·Marcel KoolUNKNOWN ICGC PedBrain Tumor Project

❮ Previous
Next ❯

Citations

Aug 31, 2016·International Journal of Oncology·Kateřina VlčkováJiri Vachtenheim
Jan 29, 2020·Cancer Metastasis Reviews·Farah RamadanRaya Saab
Nov 5, 2016·Journal of Cancer Research and Clinical Oncology·Zhongxiao LinNu Zhang
Oct 30, 2016·Cancer Medicine·Joyce G Habib, Joyce A O'Shaughnessy
Sep 29, 2015·International Journal of Oncology·Shiyuan SongGuangping Zhang
Aug 29, 2019·Cell Communication and Signaling : CCS·Giuseppina D'AlessandroCristina Limatola
Oct 23, 2019·American Journal of Medical Genetics. Part a·Steven D KleinJulian A Martinez-Agosto
Jun 25, 2015·Nature Reviews. Cancer·Venkatesh P KashiRene L Galindo
Dec 18, 2015·International Journal of Oncology·Karen A BoehmeSabine B Schleicher
Aug 31, 2018·International Journal of Molecular Sciences·Maja SabolSonja Levanat
Apr 5, 2020·Cell Communication and Signaling : CCS·Stephan J Matissek, Sherine F Elsawa
Jul 4, 2018·Molecular Cancer Therapeutics·Anke E M van ErpEmmy D G Fleuren
Jul 17, 2021·Frontiers in Oncology·Rachel Y ChowScott X Atwood

❮ Previous
Next ❯

Methods Mentioned

BETA
flow cytometry
immunoprecipitation

Software Mentioned

ImageJ
CalcuSyn

Related Concepts

Related Feeds

AKT Pathway

This feed focuses on the AKT serine/threonine kinase, which is an important signaling pathway involved in processes such as glucose metabolism and cell survival.

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis

BCL-2 Family Proteins

BLC-2 family proteins are a group that share the same homologous BH domain. They play many different roles including pro-survival signals, mitochondria-mediated apoptosis and removal or damaged cells. They are often regulated by phosphorylation, affecting their catalytic activity. Here is the latest research on BCL-2 family proteins.

Apoptotic Caspases

Apoptotic caspases belong to the protease enzyme family and are known to play an essential role in inflammation and programmed cell death. Here is the latest research.

Related Papers

Cold Spring Harbor Perspectives in Biology
Philip W Ingham
Journal of Cell Science
Markku Varjosalo, Jussi Taipale
Chirurgia narzadów ruchu i ortopedia polska
T WITWICKI, D TYLMAN
© 2022 Meta ULC. All rights reserved